Spring might have sprung this week, but plenty of investors aren't feeling warm and fuzzy. That's especially the case for shareholders of this week's three horrendous health0care stocks.

One of these stocks disappointed the market by simply announcing that a clinical study would continue. Another looks like a high-flying IPO stock that is experiencing the effects of gravity. The third stock continues to reel from reaction to an SEC investigation.

Which stocks made this week's horrendous list? Find out by watching the following slideshow.

Keith Speights has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Exelixis and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.